** Index of Australian Healthcare stocks .AXHJ rises 1.9%, tracking broadly positive market sentiment .AX
** Bell Potter says that most healthcare firms remain unaffected from tariff impacts, but Nanosonics NAN.AX, Aroa ARX.AX, and Trajan TRJ.AX, which generate significant U.S. sales from international medical devices/equipment, may be susceptible
** Neuren NEU.AX, Clarity CU6.AX and Polynovo PNV.AX are among the top gainers on the sub-index, up 20%, 6.7% and 6.3% respectively
** Brokerage expects some impact on country's biggest pharma co CSL CSL.AX given fractionation of its unit's plasma-derived products across Australia, Germany, Switzerland and the U.S.
** Adds, tariffs could impact pharma cos, but lack of details complicates potential impact assessment
** Sub-index down 12.2% YTD, compared to 5% drop in benchmark ASX 200 .AXJO
(Reporting by Kumar Tanishk in Bengaluru)
((Tanishk.Kumar@thomsonreuters.com; X: @thatstanishk http://www.x.com/thatstanishk;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。